zohman

5 POSTS 0 COMMENTS

Rivaroxaban recommended by NICE for peripheral and coronary artery disease patients

xarelto rivaroxaban
The National Institute for Health and Care Excellence (NICE) in the UK has published a positive draft final appraisal determination recommending the use of...

Alvimedica announces CE mark for Cre8 Evo 2mm

Alvimedica has announced the company has received the CE mark for the Cre8 Evo 2mm, a polymer-free Amphilimus-eluting stent. In a press release, Alvimedica states...

Society for Cardiovascular Angiography and Interventions supports continued use of paclitaxel...

SCAI
Experts from the Society for Cardiovascular Angiography and Interventions (SCAI) have reviewed the recent meta-analysis by Katsanos and colleagues and have concluded that the...

Nearly 25% of chronic ischaemic heart disease patients dead or hospitalised...

    Nearly a quarter of patients with chronic ischaemic cardiovascular disease are dead or hospitalised within six months, reports a European Society of Cardiology (ESC) study...

Analysis of LAA closure devices reveals post-approval spike in safety events

  A retrospective study conducting a safety assessment and comparison between two percutaneous devices commonly used for left atrial appendage (LAA) closure in the US­...